Showing results (421-430 of 3,371) with videos related to
Sort By:
Pageof 338
Diagnostic Microbiology and Infectious Disease|July 1, 1996
In vitro activity of quinupristin/dalfopristin (RP 59500) against a large collection of infrequently isolated or tested speciesM S Barrett, R N JonesDiagnostic Microbiology and Infectious Disease|August 1, 1997
A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wideM A Pfaller, R N JonesAmerican Journal of Clinical Pathology|October 1, 1982
The ability of participant laboratories to detect penicillin-resistant Pneumococci. A report from the microbiology portion of the College of American Pathologists (CAP) surveysR N Jones, D C EdsonAntimicrobial Agents and Chemotherapy|December 1, 1982
Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporinsR N Jones, R R PackerThe Journal of Antimicrobial Chemotherapy|April 1, 1995
Evaluation of the in-vitro activity of furopenem (SY5555 or SUN5555) against respiratory tract pathogens and beta-lactamase producing bacteriaM G Cormican, R N JonesDiagnostic Microbiology and Infectious Disease|January 1, 1996
Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive speciesD M Johnson, R N JonesDiagnostic Microbiology and Infectious Disease|April 1, 1995
Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23-6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolatesR N Jones, D M JohnsonDrugs|January 1, 1996
Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococciM G Cormican, R N JonesDiagnostic Microbiology and Infectious Disease|November 1, 1992
Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycinR N Jones, M E ErwinDiagnostic Microbiology and Infectious Disease|May 1, 1994
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate studyR N Jones, S A MarshallPageof 338